Neag, E. J.
Smith, T. J. http://orcid.org/0000-0002-6279-9685
Funding for this research was provided by:
national eye institute (EY008976)
Article History
Received: 15 July 2021
Accepted: 10 August 2021
First Online: 20 August 2021
Declarations
:
: TJS was issued US patents for the use of IGF-I receptor inhibition in the treatment of autoimmune diseases. These are held by UCLA and the Lundquist Institute. He is a paid consultant for Horizon Therapeutics.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.